Archives
-
XAV-939 Workflows for Wnt and MSC Research
2026-09-07
XAV-939, also called NVP-XAV939, gives researchers a practical way to connect tankyrase inhibition with Wnt/β-catenin pathway readouts, osteogenic differentiation, cancer research, and fibrosis models. This guide combines dose-control strategy with the scalable MSC extracellular-vesicle platform reported in a 2025 reference study, while clearly separating established evidence from proposed assay extensions.
-
iRhom2 in Olfaction: OR Regulation and Adaptation
2026-09-07
The 2024 reference study identifies iRhom2 as an olfactory sensory neuron-associated regulator linked to odorant receptor expression and activity-dependent adaptation. Its combination of mouse genetics, transcriptomics, spatial analysis, and an ectopic receptor-signaling model supports a testable iRhom2/ADAM17 pathway while also defining important limits on causal interpretation.
-
Deep Learning for iPSC-CM Cardiotoxicity Screening
2026-09-05
Grafton and colleagues developed a high-content screening workflow that combines induced pluripotent stem cell-derived cardiomyocytes with deep-learning image analysis to detect cardiotoxic phenotypes. The study shows how a single image-derived score can prioritize toxic liabilities across bioactive compounds and chemically diverse molecules, while also clarifying the limits of phenotype-based interpretation.
-
IWP-L6: Practical Porcupine Inhibitor Workflows
2026-09-04
IWP-L6 enables controlled Porcn enzyme inhibition across cell, organoid, regeneration, and osteogenic models. This guide converts its sub-nanomolar potency into practical assay designs, controls, and troubleshooting strategies for resolving Wnt ligand dependence from downstream metabolic responses.
-
Ziprasidone Augmentation in Anxious Depression
2026-09-04
This post-hoc analysis examined whether baseline anxiety altered the antidepressant or anxiolytic response to ziprasidone added to escitalopram. Depression outcomes were similar in patients with and without anxious depression, while the apparent anxiety benefit in highly anxious participants was not clinically significant, highlighting the limits of subgroup interpretation.
-
XAV-939 Workflow for Wnt Pathway Research
2026-09-03
XAV-939, also known as NVP-XAV939, gives researchers a mechanistically defined way to suppress tankyrase-dependent Wnt/β-catenin signaling in cancer, stem-cell, fibrosis, and bone models. This workflow-focused guide covers dosing logic, assay controls, pathway readouts, and troubleshooting while using a cerebral ischemia study as a practical framework for pathway validation.
-
FPR2/ALX Restricts Autoimmune Astrocytopathy
2026-09-03
The reference study identifies FPR2/ALX stimulation with Quin-C1 as a way to reduce antibody- and complement-driven astrocyte injury in a mouse model of autoimmune astrocytopathy. Its depletion and pathway-inhibition experiments connect protection to microglia, natural killer cells, and SYK-AKT signaling, offering a mechanistic framework for studying neuroinflammation in NMOSD-related pathology.
-
Silybin A and the Adipose–Liver Axis
2026-09-02
Silybin A offers a chemically defined pharmacology arm for studying oxidative stress, inflammation, and liver–adipose communication. This article integrates its assay use with targeted Fabp4 CRISPRi to improve experimental interpretation in metabolic disease research.
-
VX-765 for Caspase-1 Inflammation Research
2026-09-02
VX-765 enables selective interrogation of caspase-1-dependent cytokine release, pyroptosis, and barrier injury without treating every inflammatory signal as equivalent. This workflow-focused guide connects biochemical assays with macrophage, blood-brain barrier, rheumatoid arthritis, and HIV-associated models while emphasizing controls, dosing logic, and troubleshooting.
-
LGK-974: A Context-Aware PORCN Inhibitor
2026-09-01
LGK-974 is a potent PORCN inhibitor for separating Wnt ligand supply from downstream pathway activity. This guide connects developmental Wnt gradients with cancer assay design, emphasizing timing, spatial readouts, and dependency-aware interpretation.
-
Diethylmaleate: Turning Redox Stress Into Insight
2026-09-01
Diethylmaleate is more than a glutathione-depleting compound: it is a practical perturbation tool for testing how redox buffering shapes stress adaptation, apoptosis, and resistance. This thought-leadership article connects insecticide-resistance evidence with translational experimental design, showing how researchers can use controlled GSH depletion to distinguish GST-dependent defense from broader oxidative injury while avoiding overinterpretation across species and model systems.
-
BENPs Strengthen FLASH-RT Antitumor Effects
2026-08-31
Xu et al. developed functionalized self-assembled EGCG nanoparticles, termed BENPs, as a radiosensitizing strategy for FLASH-RT. Their findings indicate that BENPs amplify radiation-associated ROS and DNA damage while promoting tumor-cell death and broader antitumor immune activation, although further work is needed to establish formulation, dose, and clinical transferability.
-
Direct Mouse Genotyping Kit Plus for Lineage Studies
2026-08-31
The Direct Mouse Genotyping Kit Plus supports rapid, purification-free PCR for mouse model verification. This article presents a provenance-centered strategy for connecting allele identity with lineage-tracing and macrophage biology while clarifying assay limits and validation decisions.
-
Difloxacin HCl for Reliable Cell Assays
2026-08-30
Difloxacin HCl (SKU A8411) can help researchers design better-controlled antimicrobial susceptibility, multidrug-resistance, and cell-based viability workflows. This scenario-driven guide explains formulation limits, assay controls, interpretation boundaries, and practical product-selection criteria.
-
SM-164 Workflows for IAP-Driven Apoptosis
2026-08-29
SM-164 is a bivalent Smac mimetic for dissecting cIAP-1/2 degradation, XIAP antagonism, and TNFα-dependent apoptosis in tumor models. This practical guide translates its mechanism into reproducible cell-based assays, orthogonal caspase readouts, and troubleshooting decisions for cancer research.